CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma Interventions: Procedure: CS1-CAR T Therapy; Drug: Cyclophosphamide; Drug: Fludarabine; Procedure: Leukapheresis Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials